Vorinostat modulates the expression of the progesterone receptor in subtypes of triple-negative breast cancer cell lines

被引：0
|
作者：
Lyn-Cook, Beverly [1 ]
NouriEmamzadeh, Fatemeh [1 ]
Word, Beverly [1 ]
Moore, Rhonda [2 ]
Miranda-Carboni, Gustav [3 ]
机构：
[1] US FDA, Jefferson, AR USA
[2] US FDA, White Oak, MD USA
[3] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2018年 / 27卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B46
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [31] Prognostic tumor microenvironment subtypes in triple-negative breast cancer
    Eng, Jennifer R.
    Bucher, Elmar
    Hu, Zhi
    Sanders, Melinda
    Chakravarthy, Bapsi
    Gibbs, Summer
    Chin, Koei
    Pietenpol, Jennifer
    Gray, Joe W.
    CANCER RESEARCH, 2022, 82 (12)
  • [32] Novel prognostic stromal subtypes in triple-negative breast cancer
    Thompson, Crista
    Saleh, Sadiq M.
    Bertos, Nicholas
    Gigoux, Mathieu
    Gruosso, Tina
    Souleimanova, Margarita
    Zhao, Hong
    Hallett, Michael T.
    Park, Morag
    CANCER RESEARCH, 2016, 76
  • [33] Identifying specific inhibitors of triple-negative breast cancer subtypes
    Robles, A. J.
    Cai, S.
    Du, L.
    Shaffer, C. V.
    Grkovic, T.
    Risinger, A. L.
    O'Keefe, B. R.
    Cichewicz, R. H.
    Mooberry, S. L.
    PLANTA MEDICA, 2016, 82
  • [34] Correlation of TILs and molecular Subtypes of triple-negative Breast Cancer
    Schueler, K.
    Hartung, C.
    Bauer, M.
    Staege, M.
    Kaufhold, S.
    Kantelhardt, E.
    Thomssen, C.
    Vetter, M.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (06) : E31 - E32
  • [35] Clinicopathological Features of Triple-Negative Breast Cancer Epigenetic Subtypes
    DiNome, Maggie L.
    Orozco, Javier I. J.
    Matsuba, Chikako
    Manughian-Peter, Ayla O.
    Ensenyat-Mendez, Miquel
    Chang, Shu-Ching
    Jalas, John R.
    Salomon, Matthew P.
    Marzese, Diego M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (10) : 3344 - 3353
  • [36] Triple-negative breast cancer: molecular subtypes and targeted therapy
    Hirshfield, Kim M.
    Ganesan, Shridar
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (01) : 34 - 40
  • [37] Impact of genetic ancestry in triple-negative breast cancer subtypes
    Mesrizadeh, Zahra
    Mukund, Kavitha
    Hossain, Fokrul
    Zabaleta, Jovanny
    Danos, Denise
    De Valle, Luis
    Wu, Xiao-Cheng
    Hicks, Chindo
    Ochoa, Augusto
    Miele, Lucio
    Seewaldt, Victoria L.
    Subramaniam, Shankar
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [38] Vorinostat and indole-3-carbinol modulate microRNAs and histone deacetylase activity in subtypes of triple-negative breast cancer
    Lyn-Cook, Beverly
    NouriEmamzaden, Fatemeh
    Hawkins, Anfernee
    Hammons, George
    Word, Beverly
    CANCER RESEARCH, 2018, 78 (13)
  • [39] The Wnt3a targetome in triple-negative breast cancer cell lines
    Maubant, Sylvie
    Tesson, Bruno
    Maire, Virginie
    Ye, Mengliang
    Rigaill, Guillem
    Gentien, David
    Cruzalegui, Francisco
    Tucker, Gordon C.
    Roman-Roman, Sergio
    Dubois, Thierry
    CANCER RESEARCH, 2015, 75
  • [40] Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines
    Taurin, Sebastien
    Rosengren, Rhonda J.
    MEDICAL ONCOLOGY, 2022, 40 (01)
12345